releases: https://www.curtis.senate.gov/press-releases/curtis-rosen-introduce-bipartisan-bill-to-lower-costs-of-medications-medical-devices
Data license: MIT · Data source: dwillis/congress-press
This data as json
| url | title | date | year | month | party | chamber | state | member_name | bioguide_id | domain | scraper | source | date_source | text | has_text | collected_at | updated_at |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| https://www.curtis.senate.gov/press-releases/curtis-rosen-introduce-bipartisan-bill-to-lower-costs-of-medications-medical-devices | Curtis, Rosen Introduce Bipartisan Bill to Lower Costs of Medications, Medical Devices | 2025-12-04 | 2025 | 2025-12 | Republican | Senate | UT | John R. Curtis | C001114 | www.curtis.senate.gov | curtis | https://www.curtis.senate.gov/newsroom/press-releases | scraper | Washington, D.C. – Today, U.S. Senators Jacky Rosen (D-NV) and John Curtis (R-UT) introduced a bill to help reduce the cost of prescription drugs and medical devices, prevent drug shortages, boost domestic production, and create more jobs. Their bipartisan Expanding Access to Affordable Prescription Drugs and Medical Devices Act will create a clear pathway for nonprofit drug and medical device manufacturers to receive tax-exempt status, to support this critical industry and bolster nonprofit manufacturer production so more Americans can have access to lower cost medicine. “As Nevadans continue being squeezed by rising costs, I’m working to lower costs any way I can,” said Senator Rosen. “Whether it’s access to cancer-treating medication or insulin pumps, this bipartisan bill would help reduce costs by bringing medications and devices to the market at a reasonable price, while creating jobs right here at home. I will never stop fighting to ensure Nevadans can access the affordable medical care they depend on.” “So much of what is lost in our conversation about healthcare is the true cost associated with medications and medical devices,” said Senator Curtis. “Utahns and their families look to Congress to help cut red tape and streamline innovation, and alongside Senator Rosen, this legislation will help secure the domestic supply chain and empower nonprofit manufacturers to improve our most vulnerable health care markets.” “We appreciate the attention of Congress to the non-profit pharmaceutical model,” said Ned McCoy, President and CEO of Civica Rx. “This helps advance our mission to address drug shortages and ensure fair drug prices for consumers.” “Nonprofit pharmaceutical companies are tackling important public health needs and drug supply challenges—such as drug shortages and high prices—that aren’t being effectively addressed by traditional companies,” said Dan Liljenquist, Chief Strategy Officer at Intermountain Health. “This legislation will help additional companies deliver on their important nonprofit missions.” | 1 | 2026-03-30T01:40:41Z | 2026-04-06T20:09:11Z |